MedDataX Logo

Chemotherapy With DNA Damaging Agents In Colorectal Cancer

NCT ID: NCT01456923

Last Updated: 2011-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Primary Study Purpose

TREATMENT

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control (chemotherapy and surgery)

Patients treated with chemotherapy + surgery

Group Type ACTIVE_COMPARATOR

Treatment with chemotherapy

Intervention Type OTHER

surgery

Intervention Type PROCEDURE

Study

Patients treated only with chemotherapy

Group Type ACTIVE_COMPARATOR

Only chemotherapy treatment for study cohort

Intervention Type OTHER

Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment with chemotherapy

Intervention Type OTHER

Only chemotherapy treatment for study cohort

Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy

Intervention Type OTHER

surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- patients that did not underwent surgery

Exclusion Criteria

\- patients that underwent surgery
Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centro Hospitalar Nordeste

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ana Cadavez Pedro

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACCRC10

Identifier Type: -

Identifier Source: org_study_id